5 new clinical trials for TNBC, HER2 positive, and other subtypes of stage IV breast cancer (stage 4) have been added to BreastCancerTrials.org (BCT) in the last month.  These clinical trials can also be found on Metastatic Trial Search (MTS).

Stage IV Triple Negative Breast Cancer

• AZD5153 Alone or With Olaparib in Advanced Triple Negative Breast Cancer

Stage IV HR Positive (HR+) Breast Cancer

• Chemotherapy Plus One or Two Immunotherapies for Women With Advanced ER Positive, HER2 Negative Breast Cancer
• Fulvestrant With or Without Capivasertib In Advanced ER Positive, HER2 Negative Breast Cancer
• Fulvestrant & Abemaciclib With and Without Copanlisib in Metastatic Hormone Positive, HER2 Negative Breast Cancer

Stage IV HER2 Positive Breast Cancer 

• MEN1611 & Trastuzumab In Advanced HER2 Positive Breast Cancer With A PIK3CA Mutation

Last Modified on July 24, 2020